ARBK vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: May 27, 2026

ARBK

49.2
AI Score
VS
HIVE Wins

HIVE

58.3
AI Score

Investment Advisor Scores

ARBK

49score
Recommendation
HOLD

HIVE

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ARBK HIVE Winner
Forward P/E 100 68.0272 HIVE
PEG Ratio 0 0 Tie
Revenue Growth -74.7% 218.6% HIVE
Earnings Growth -94.0% -99.9% ARBK
Tradestie Score 49.2/100 58.3/100 HIVE
Profit Margin 32.8% -48.6% ARBK
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.